Pharma IQ

SEPTEMBER 5, 2024

Explore how digital transformation, particularly cloud technology and AI enhances efficiency and patient outcomes.

Healthcare 204

Healthcare Healthcare Patients 204

Fierce Pharma

SEPTEMBER 5, 2024

AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case. | AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case.

Insurance 321

Insurance Patients 321

MedCity News

SEPTEMBER 4, 2024

Eli Lilly now offers vials of obesity medication Zepbound directly to self-pay patients at a nearly 50% discount off the drug’s list price. But more than offering patients a lower-cost alternative, this move represents a strategic stance against certain pharmaceutical industry players. The post With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and PBMs appeared first on MedCity News.

Patients 125

Patients Medical Pharmaceutical Biopharma 125

Pharmaceutical Technology

SEPTEMBER 6, 2024

The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD-147 aimed at neuroendocrine carcinoma.

FDA 124

FDA 124

Advertiser: ZoomInfo

Savvy B2B marketers know that a great account-based marketing (ABM) strategy leads to higher ROI and sustainable growth. In this guide, we’ll cover: What makes for a successful ABM strategy? What are the key elements and capabilities of ABM that can make a real difference? How is AI changing workflows and driving functionality? This Martech Intelligence Report on Enterprise Account-Based Marketing examines the state of ABM in 2024 and what to consider when implementing ABM software.

Marketing

PharmaTech

SEPTEMBER 5, 2024

Qualifying material suppliers is a crucial step in ensuring safe and effective drug products.

118

118

Fierce Pharma

SEPTEMBER 4, 2024

Over the last decade, three blockbuster drugs—Biogen’s Spinraza, Roche’s Evrysdi and Novartis’ gene therapy Zolgensma—have transformed the treatment landscape for spinal muscular atrophy (SMA). | Biogen revealed that a portion of its phase 2/3 DEVOTE study met its primary endpoint, as a higher dose of Spinraza improved the motor function of treatment-naive infants with spinal muscular atrophy.

288

288

Pharmaceutical Commerce

SEPTEMBER 3, 2024

How can industry stakeholders ensure the quality and supply chain security of existing product?

111

111

European Pharmaceutical Review

SEPTEMBER 5, 2024

The Medicines and Healthcare Products Regulatory Agency (MHRA) has licenced the first treatment (oral gonadotropin-releasing hormone [GnRH] receptor antagonist) in a new class of medicines for women in the UK with endometriosis. Relugolix combination therapy, Ryeqo (relugolix 40mg, estradiol 1mg, and norethisterone acetate 0.5mg), is authorised to treat endometriosis symptoms in adults.

Medicine 110

Medicine Medical Healthcare Healthcare 110

Fierce Pharma

SEPTEMBER 5, 2024

Johnson & Johnson’s newly FDA-approved lung cancer combination of Rybrevant and Lazcluze is inching ever closer to a statistically significant survival showing, which could help it better chall | Johnson & Johnson’s newly FDA-approved lung cancer combination of Rybrevant and Lazcluze is inching ever closer to a statistically significant survival showing, which could help it better challenge AstraZeneca’s Tagrisso.

FDA 268

FDA 268

pharmaphorum

SEPTEMBER 5, 2024

EU General Court suspends decision to revoke the license for Advanz Pharma's primary biliary cholangitis drug Ocaliva.

Pharma 111

Pharma 111

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

MedCity News

SEPTEMBER 4, 2024

In this episode, we’re joined by Carolee Lee, CEO and founder of Women’s Health Access Matters (WHAM), and Ash Shehata, KPMG U.S. sector leader for healthcare. The two discuss WHAM and KPMG’s new partnership that aims to advance women’s health research and investment. The post MedCity FemFwd: Inside WHAM & KPMG’s Women’s Health Partnership appeared first on MedCity News.

Healthcare 109

Healthcare Healthcare 109

Pharmaceutical Technology

SEPTEMBER 2, 2024

Aptose Biosciences has secured a loan of $10m through a facility agreement with Hanmi Pharmaceutical to develop tuspetinib.

Pharmaceutical 110

Pharmaceutical 110

Fierce Pharma

SEPTEMBER 5, 2024

With dwindling funds after a prior snub from the FDA, ImmunityBio’s journey to bag approval for its Merck-rivaling bladder cancer drug Anktiva wasn’t easy. | The drugmaker laid off 20 employees as it attempts to recoup from dwindling funds during its Anktiva launch in bladder cancer.

FDA 264

FDA 264

pharmaphorum

SEPTEMBER 5, 2024

Listen to the podcast interview with Manny Belabe from ArisGlobal as he discusses The Life Sciences Generative AI Council and its role in creating a sustainable technological future. Gain insights into the future of AI in life sciences.

106

106

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

SEPTEMBER 6, 2024

By 2030, the U.S. expects shortages of 200,000 nurses and 124,000 physicians snd similar shortages are already being felt in the U.K. and elsewhere. Here’s how to build and train a modern healthcare workforce in the age of AI The post Can AI Help Fix Our Demographic Time Bomb? appeared first on MedCity News.

Physicians 105

Physicians Training Healthcare Healthcare 105

Pharmaceutical Technology

SEPTEMBER 3, 2024

The UAE has partnered with Novo Nordisk Pharma Gulf to develop a national scientific guide for obesity management and weight control.

Management 107

Management Pharma 107

Fierce Pharma

SEPTEMBER 3, 2024

Late last year, Novo Nordisk responded to a growing shortage of popular Ozempic with a plan to cut down on production of its older diabetes med Victoza to make room for more Ozempic. | The company and the European Medicines Agency warned European healthcare providers to continue limiting new patient prescriptions until the shortages let up.

Healthcare Provider 256

Healthcare Provider Prescription Medicine Healthcare 256

Pharmaceutical Commerce

SEPTEMBER 5, 2024

In the second part of her interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, discusses the best practices that compliance teams should consider as the end of the stabilization period approaches this November.

Pharma 105

Pharma 105

Advertisement

MedCity News

SEPTEMBER 5, 2024

Let’s envision a healthcare system where caregiving is valued as the essential work it is. Where technology and policy work hand in hand and no one has to choose between caring for a loved one and pursuing their own health and career goals. The post While America Rested on Labor Day, The Invisible Healthcare Workforce Carried On appeared first on MedCity News.

Healthcare 104

Healthcare Healthcare 104

Pharmaceutical Technology

SEPTEMBER 2, 2024

The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the past two weeks.

FDA 105

FDA 105

Fierce Pharma

SEPTEMBER 4, 2024

Several months after its parent company unveiled new labs and office space to unite cell and gene therapy research on the West Coast, Astellas Gene Therapies is turning out the lights at a Californ | Several months after its parent company unveiled new labs and office space to unite cell and gene therapy research on the West Coast, Astellas Gene Therapies is turning out the lights at a California production plant.

253

253

Pharmaceutical Commerce

SEPTEMBER 5, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution 105

Distribution Biopharma Pharma Marketing 105

Advertiser: ZoomInfo

Over the last two years, there’s been a 76 percent increase in AI adoption across sales organizations. The reason for its rise? AI increases teams’ productivity by predicting and automating actions that require manual effort. In other words, the research that takes reps hours, AI can do in seconds. For sales teams, AI opens up a world of new possibilities, including automating outreach, identifying best-fit buyers, and keeping CRMs flush with fresh data.

Sales

PharmaVoice

SEPTEMBER 4, 2024

More companies are investing in protein degraders, which leverage a unique approach to harnessing the immune system in cancer, neurological diseases and more.

104

104

Pharmaceutical Technology

SEPTEMBER 4, 2024

Actimed says S-oxprenolol shares a similar pharmacology to its lead product S-pindolol, which is being studied in cachexia.

Pharmacology 105

Pharmacology FDA Leads 105

Fierce Pharma

SEPTEMBER 4, 2024

With a shortage of ADHD drugs persisting, the DEA has raised production limits on Takeda’s Vyvanse and its generic versions by 24%, the agency said.

246

246

Pharmaceutical Commerce

SEPTEMBER 3, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, highlights the hard-hitting points that she anticipated will be covered during her session at the 2024 HDA Traceability Seminar.

Pharma 105

Pharma 105

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaTimes

SEPTEMBER 6, 2024

New treatment could simplify diabetes management for millions

Management 103

Management 103

Pharmaceutical Technology

SEPTEMBER 2, 2024

GLP-1RAs’ reduce CV risk, including reducing all-cause mortality and risk of MI, promoting weight loss and enhancing blood pressure control.

105

105

Fierce Pharma

SEPTEMBER 6, 2024

Gilead Sciences has been looking for a win for Trodelvy after two surprise trial failures earlier this year. | Gilead Sciences has been looking for a win for Trodelvy after two surprise trial failures earlier this year. But it looks like that win won’t come from a triplet regimen that combines the antibody-drug conjugate with Merck’s Keytruda and chemotherapy in newly diagnosed non-small cell lung cancer.

235

235

Pharmaceutical Commerce

SEPTEMBER 3, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma 105

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety